World News: 13:55 GMT Friday 12th October 2018. [Research and Markets via Globe Newswire via SPi World News]
Dublin, Oct. 12, 2018 (GLOBE NEWSWIRE) -- The report has been added to offering.
The global wearable injectors market is projected to reach USD 9.41 billion by 2023 from an estimated USD 5.57 billion in 2018, at a CAGR of 11.1% during the forecast period.
The growing prevalence of targeted therapies, favorable reimbursement, and technological advancements in wearable injectors are expected to drive the growth of the wearable injectors market. However, the preference for alternative routes of drug delivery such as pens & autoinjectors is expected to restrain the growth of this market to a certain extent.Based on type, the market is segmented into on-body and off-body injectors. The off-body injectors segment is expected to register the highest CAGR during the forecast period. The drawbacks associated with on-body wearable injectors, such as painful removal, skin sensitivity issues and irritation, and adhesive fitting issues have resulted in the increased demand for off-body injectors.
Based on therapy, the global wearable injectors market is segmented into immuno-oncology, diabetes, cardiovascular diseases, and other therapies (Parkinson's Disease, thalassemia, and primary immunodeficiency disorders).
The cardiovascular diseases segment is expected to witness the highest CAGR during the forecast period. The high growth of the segment can be primarily attributed to the high burden of CVDs across the globe coupled with the growing availability of wearable injectors for the treatment of CVDs.North America is expected to witness the highest growth from 2018 to 2023. This can be attributed to the rising prevalence of chronic diseases in the US and Canada; favorable reimbursement scenarios; and an increasing number of awareness programs in the US and Canada.The report analyzes the wearable injectors market and aims at estimating the market size and future growth potential of this market based on various segments such as type, therapy, and region. The report also includes competitive analysis of the key players in this market along with their company profiles, product and service offerings, recent developments, and key market strategies.
For more information about this report visit
Did you know that we also offer Custom Research? Visit our page to learn more and schedule a meeting with our Custom Research Manager.
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Infusions and Injectables , Needles and Syringes
Globe Newswire: 13:55 GMT Friday 12th October 2018
SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2018. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 0751938.